Endocrinology, Vol 133, 2461-2468, Copyright © 1993 by Endocrine Society

ARTICLES

Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats

K Schotanus, FJ Tilders and F Berkenbosch
Vrije Universiteit, Faculty of Medicine, Department of Pharmacology, Amsterdam, The Netherlands.

The present study was designed to analyze the role of endogenous interleukin-1 (IL-1) in the ACTH, corticosterone (CORT), and IL-6 responses of rats to bacterial endotoxin. Recombinant rat IL-1 beta (rIL-1 beta) when given ip resulted in dose-dependent increases in plasma ACTH, CORT, and IL-6 concentrations. Plasma ACTH and CORT responses could be induced by low rIL-1 beta doses that did not elevate plasma IL-6 levels. The half-maximally effective dose of rIL-1 beta was less than 0.6 microgram/kg for the ACTH and CORT responses and higher than 2.5 micrograms/kg for the IL-6 response. Time-course studies indicated that plasma ACTH and CORT concentrations were already elevated 30 min after the injection of rIL-1 beta (2.5 micrograms/kg, ip), with peak values after 1-2 h, followed by a subsequent decline. In contrast, plasma IL-6 concentrations became elevated 2 h after the injection of rIL-1 beta. In another set of experiments, the administration of endotoxin resulted in a dose-dependent elevation of the plasma ACTH, CORT, and IL-6 concentrations. The dose-response characteristics for ACTH, CORT, and IL-6 were different. The half- maximally effective dose for the ACTH and CORT, and IL-6 responses were approximately 2.5 micrograms/kg and more than 10 micrograms/kg, respectively. Time courses of plasma ACTH, CORT, and IL-6 responses to endotoxin (2.5 micrograms/kg, ip) were similar, with peak values measured after 2 h. When given alone, the human IL-1 receptor antagonist (IL-1RA; 1 or 2.5 mg/kg, ip) did not affect resting plasma ACTH and CORT concentrations and reduced plasma IL-6 concentrations in one experiment. At a dose of 1 mg/kg, IL-1RA inhibited ACTH and IL-6 responses to rIL-1 beta (2.5 micrograms/kg, ip) by 75% and 90%, respectively. Administration of IL-1RA (2.5 mg/kg, ip) 30 min after endotoxin (2.5 micrograms/kg, ip) completely prevented the ACTH response and partially inhibited the CORT response, but did not affect the IL-6 response measured 2.5 h after endotoxin administration. We conclude that 1) IL-1 receptors are involved in the ACTH and IL-6 responses to rat IL-1 beta; 2) the ACTH response, but not the IL-6 response, to a low dose dose of endotoxin in rats requires IL-1 receptor activation by endogenous produced IL-1; and 3) circulating IL- 6 is not a prime mediator involved in ACTH and CORT responses to low doses of rIL-1 beta and endotoxin.

This article has been cited by other articles:

				J. Campisi,, M. K. Hansen,, K. A. O'Connor,, J. C. Biedenkapp,, L. R. Watkins,, S. F. Maier,, and M. Fleshner Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge J Appl Physiol, November 1, 2003; 95(5): 1873 - 1882. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				L. E. Goehler, R. P. A. Gaykema, K. T. Nguyen, J. E. Lee, F. J. H. Tilders, S. F. Maier, and L. R. Watkins Interleukin-1beta in Immune Cells of the Abdominal Vagus Nerve: a Link between the Immune and Nervous Systems? J. Neurosci., April 1, 1999; 19(7): 2799 - 2806. [Abstract] [Full Text] [PDF]

				M. J. P. Lenczowski, R.-M. Bluthe, J. Roth, G. S. Rees, D. A. Rushforth, A.-M. van Dam, F. J. H. Tilders, R. Dantzer, N. J. Rothwell, and G. N. Luheshi Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R652 - R658. [Abstract] [Full Text] [PDF]

				M. J. P. Lenczowski, A.-M. Van Dam, S. Poole, J. W. Larrick, and F. J. H. Tilders Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1870 - R1877. [Abstract] [Full Text] [PDF]

				A. V. Turnbull, F. J. Pitossi, J.-J. Lebrun, S. Lee, J. C. Meltzer, D. M. Nance, A. del Rey, H. O. Besedovsky, and C. Rivier Inhibition of Tumor Necrosis Factor-alpha Action within the CNS Markedly Reduces the Plasma Adrenocorticotropin Response to Peripheral Local Inflammation in Rats J. Neurosci., May 1, 1997; 17(9): 3262 - 3273. [Abstract] [Full Text] [PDF]

				J.-M. Aubry, A. V. Turnbull, G. Pozzoli, C. Rivier, and W. Vale Endotoxin Decreases Corticotropin-Releasing Factor Receptor 1 Messenger Ribonucleic Acid Levels in the Rat Pituitary Endocrinology, April 1, 1997; 138(4): 1621 - 1626. [Abstract] [Full Text] [PDF]